(KEYS) Keysight Technologies - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US49338L1035
Oscilloscopes, Analyzers, Generators, Software, Services
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 32.2% |
| Value at Risk 5%th | 45.8% |
| Relative Tail Risk | -13.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 4.06 |
| CAGR/Max DD | 0.17 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.594 |
| Beta | 1.314 |
| Beta Downside | 1.523 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.71% |
| Mean DD | 17.05% |
| Median DD | 16.56% |
Description: KEYS Keysight Technologies December 17, 2025
Keysight Technologies (NYSE: KEYS) designs and manufactures electronic test and measurement equipment, serving customers worldwide through two business units: Communications Solutions and Electronic Industrial Solutions. Its product portfolio spans oscilloscopes, spectrum and network analyzers, signal generators, 5G test gear, and a suite of software tools for design automation, workflow, and security testing, complemented by extensive support and integration services.
In FY 2023 the company reported revenue of roughly $6.0 billion and GAAP earnings per share of $5.60, with research-and-development spending hovering around 15 % of sales-a level that underscores its focus on staying ahead in fast-moving segments such as 5G NR base-station testing and semiconductor validation.
Key macro drivers for Keysight include the global semiconductor capital-expenditure cycle, which fuels demand for high-precision test equipment, and rising defense and aerospace budgets that sustain long-term contracts for ruggedized test systems. Additionally, the acceleration of cloud-based network monitoring and cybersecurity testing creates cross-selling opportunities for its software-enabled solutions.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of KEYS valuation metrics and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (846.0m TTM) > 0 and > 6% of Revenue (6% = 322.5m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 2.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.47% (prev 56.84%; Δ -10.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 1.41b > Net Income 846.0m (YES >=105%, WARN >=100%) |
| Net Debt (1.10b) to EBITDA (1.43b) ratio: 0.77 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (173.0m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 62.08% (prev 62.92%; Δ -0.84pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.28% (prev 53.72%; Δ -1.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.98 (EBITDA TTM 1.43b / Interest Expense TTM 96.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.57
| (A) 0.22 = (Total Current Assets 4.35b - Total Current Liabilities 1.85b) / Total Assets 11.29b |
| (B) 0.63 = Retained Earnings (Balance) 7.07b / Total Assets 11.29b |
| (C) 0.11 = EBIT TTM 1.15b / Avg Total Assets 10.28b |
| (D) 1.26 = Book Value of Equity 6.83b / Total Liabilities 5.42b |
| Total Rating: 5.57 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.52
| 1. Piotroski 6.50pt |
| 2. FCF Yield 3.93% |
| 3. FCF Margin 26.21% |
| 4. Debt/Equity 0.51 |
| 5. Debt/Ebitda 0.77 |
| 6. ROIC - WACC (= 1.33)% |
| 7. RoE 15.24% |
| 8. Rev. Trend -15.80% |
| 9. EPS Trend -53.49% |
What is the price of KEYS shares?
As of December 23, 2025, the stock is trading at USD 203.71 with a total of 761,170 shares traded.
Over the past week, the price has changed by -1.82%, over one month by +14.66%, over three months by +14.56% and over the past year by +25.20%.
Over the past week, the price has changed by -1.82%, over one month by +14.66%, over three months by +14.56% and over the past year by +25.20%.
Is KEYS a buy, sell or hold?
Keysight Technologies has received a consensus analysts rating of 4.23.
Therefore, it is recommended to buy KEYS.
- Strong Buy: 6
- Buy: 5
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the KEYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 219.8 | 7.9% |
| Analysts Target Price | 219.8 | 7.9% |
| ValueRay Target Price | 210 | 3.1% |
KEYS Fundamental Data Overview December 22, 2025
Market Cap USD = 34.79b (34.79b USD * 1.0 USD.USD)
P/E Trailing = 40.3327
P/E Forward = 24.9377
P/S = 6.4722
P/B = 5.9153
P/EG = 1.5312
Beta = 1.196
Revenue TTM = 5.38b USD
EBIT TTM = 1.15b USD
EBITDA TTM = 1.43b USD
Long Term Debt = 2.53b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 2.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.10b USD (from netDebt column, last quarter)
Enterprise Value = 35.89b USD (34.79b + Debt 2.97b - CCE 1.87b)
Interest Coverage Ratio = 11.98 (Ebit TTM 1.15b / Interest Expense TTM 96.0m)
FCF Yield = 3.93% (FCF TTM 1.41b / Enterprise Value 35.89b)
FCF Margin = 26.21% (FCF TTM 1.41b / Revenue TTM 5.38b)
Net Margin = 15.74% (Net Income TTM 846.0m / Revenue TTM 5.38b)
Gross Margin = 62.08% ((Revenue TTM 5.38b - Cost of Revenue TTM 2.04b) / Revenue TTM)
Gross Margin QoQ = 61.24% (prev 61.69%)
Tobins Q-Ratio = 3.18 (Enterprise Value 35.89b / Total Assets 11.29b)
Interest Expense / Debt = 0.94% (Interest Expense 28.0m / Debt 2.97b)
Taxrate = 21.74% (70.0m / 322.0m)
NOPAT = 900.0m (EBIT 1.15b * (1 - 21.74%))
Current Ratio = 2.35 (Total Current Assets 4.35b / Total Current Liabilities 1.85b)
Debt / Equity = 0.51 (Debt 2.97b / totalStockholderEquity, last quarter 5.88b)
Debt / EBITDA = 0.77 (Net Debt 1.10b / EBITDA 1.43b)
Debt / FCF = 0.78 (Net Debt 1.10b / FCF TTM 1.41b)
Total Stockholder Equity = 5.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.49% (Net Income 846.0m / Total Assets 11.29b)
RoE = 15.24% (Net Income TTM 846.0m / Total Stockholder Equity 5.55b)
RoCE = 14.22% (EBIT 1.15b / Capital Employed (Equity 5.55b + L.T.Debt 2.53b))
RoIC = 11.39% (NOPAT 900.0m / Invested Capital 7.90b)
WACC = 10.06% (E(34.79b)/V(37.76b) * Re(10.86%) + D(2.97b)/V(37.76b) * Rd(0.94%) * (1-Tc(0.22)))
Discount Rate = 10.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.14%
[DCF Debug] Terminal Value 71.23% ; FCFE base≈1.20b ; Y1≈1.39b ; Y5≈1.96b
Fair Price DCF = 125.4 (DCF Value 21.55b / Shares Outstanding 171.8m; 5y FCF grow 17.99% → 3.0% )
EPS Correlation: -53.49 | EPS CAGR: 3.98% | SUE: 0.48 | # QB: 0
Revenue Correlation: -15.80 | Revenue CAGR: 3.44% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-01-31): EPS=1.99 | Chg30d=+0.150 | Revisions Net=+8 | Analysts=12
EPS current Year (2026-10-31): EPS=8.09 | Chg30d=+0.288 | Revisions Net=+10 | Growth EPS=+13.0% | Growth Revenue=+15.1%
EPS next Year (2027-10-31): EPS=9.27 | Chg30d=+0.355 | Revisions Net=+7 | Growth EPS=+14.5% | Growth Revenue=+6.4%
P/E Trailing = 40.3327
P/E Forward = 24.9377
P/S = 6.4722
P/B = 5.9153
P/EG = 1.5312
Beta = 1.196
Revenue TTM = 5.38b USD
EBIT TTM = 1.15b USD
EBITDA TTM = 1.43b USD
Long Term Debt = 2.53b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 2.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.10b USD (from netDebt column, last quarter)
Enterprise Value = 35.89b USD (34.79b + Debt 2.97b - CCE 1.87b)
Interest Coverage Ratio = 11.98 (Ebit TTM 1.15b / Interest Expense TTM 96.0m)
FCF Yield = 3.93% (FCF TTM 1.41b / Enterprise Value 35.89b)
FCF Margin = 26.21% (FCF TTM 1.41b / Revenue TTM 5.38b)
Net Margin = 15.74% (Net Income TTM 846.0m / Revenue TTM 5.38b)
Gross Margin = 62.08% ((Revenue TTM 5.38b - Cost of Revenue TTM 2.04b) / Revenue TTM)
Gross Margin QoQ = 61.24% (prev 61.69%)
Tobins Q-Ratio = 3.18 (Enterprise Value 35.89b / Total Assets 11.29b)
Interest Expense / Debt = 0.94% (Interest Expense 28.0m / Debt 2.97b)
Taxrate = 21.74% (70.0m / 322.0m)
NOPAT = 900.0m (EBIT 1.15b * (1 - 21.74%))
Current Ratio = 2.35 (Total Current Assets 4.35b / Total Current Liabilities 1.85b)
Debt / Equity = 0.51 (Debt 2.97b / totalStockholderEquity, last quarter 5.88b)
Debt / EBITDA = 0.77 (Net Debt 1.10b / EBITDA 1.43b)
Debt / FCF = 0.78 (Net Debt 1.10b / FCF TTM 1.41b)
Total Stockholder Equity = 5.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.49% (Net Income 846.0m / Total Assets 11.29b)
RoE = 15.24% (Net Income TTM 846.0m / Total Stockholder Equity 5.55b)
RoCE = 14.22% (EBIT 1.15b / Capital Employed (Equity 5.55b + L.T.Debt 2.53b))
RoIC = 11.39% (NOPAT 900.0m / Invested Capital 7.90b)
WACC = 10.06% (E(34.79b)/V(37.76b) * Re(10.86%) + D(2.97b)/V(37.76b) * Rd(0.94%) * (1-Tc(0.22)))
Discount Rate = 10.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.14%
[DCF Debug] Terminal Value 71.23% ; FCFE base≈1.20b ; Y1≈1.39b ; Y5≈1.96b
Fair Price DCF = 125.4 (DCF Value 21.55b / Shares Outstanding 171.8m; 5y FCF grow 17.99% → 3.0% )
EPS Correlation: -53.49 | EPS CAGR: 3.98% | SUE: 0.48 | # QB: 0
Revenue Correlation: -15.80 | Revenue CAGR: 3.44% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-01-31): EPS=1.99 | Chg30d=+0.150 | Revisions Net=+8 | Analysts=12
EPS current Year (2026-10-31): EPS=8.09 | Chg30d=+0.288 | Revisions Net=+10 | Growth EPS=+13.0% | Growth Revenue=+15.1%
EPS next Year (2027-10-31): EPS=9.27 | Chg30d=+0.355 | Revisions Net=+7 | Growth EPS=+14.5% | Growth Revenue=+6.4%
Additional Sources for KEYS Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle